# Prognostic significance of compliance with fractional flow reserve guidance on diverse vessel-related clinical outcomes

**Authors:** Yang Zhang, Bangguo Yang, Yicong Ye, Xiliang Zhao, Yaodong Ding, Yi Ye, Liang Zhang, Dawei Tan, Gong Zhang, Xiaoyu Duan, Quan Li, Yong Zeng

PMC · DOI: 10.3389/fcvm.2024.1370345 · Frontiers in Cardiovascular Medicine · 2024-05-17

## TL;DR

This study examines how following fractional flow reserve (FFR) guidance affects clinical outcomes in coronary artery disease patients.

## Contribution

The study introduces a novel analysis of FFR compliance effects on both target and non-target vessel outcomes using IPTW adjustment.

## Key findings

- FFR-based treatment significantly reduces the risk of target vessel failure.
- Non-target vessel failure and composite endpoints show no significant intergroup differences.
- Non-target vessel events dilute the observed benefits of FFR-guided treatment.

## Abstract

In patients underwent fractional flow reserve (FFR) assessment, a noteworthy proportion of adverse events occur in vessels in which FFR has not been measured. However, the effect of these non-target vessel-related events on the evaluation of FFR-related benefits remains unknown.

In this retrospective study, vessels subjected to FFR measurement were grouped as FFR-based approach and non-compliance with FFR based on whether they received FFR-based treatment. Using inverse probability of treatment weighting (IPTW) to account for potential confounding, we investigated the association between compliance with FFR and 5-year target vessel failure (TVF) non-target vessel failure (NTVF) and vessel-oriented composite endpoints (VOCEs). Of the 1,119 vessels, 201 did not receive FFR-based treatment. After IPTW adjustment, a signiﬁcantly lower hazard of TVF was observed in the FFR-based approach group (HR: 0.56; 95% CI: 0.34–0.92). While, the intergroup difference in hazard of NTVF (HR: 1.02; 95% CI: 0.45–2.31) and VOCEs (HR: 0.69; 95% CI: 0.45–1.05) were nonsignificant.

In patients with CAD subjected to FFR, the FFR-based treatment yields a sustained clinical benefit in terms of the risks of target vessel-related events. The dilution of non-target vessel-related events renders the difference favoring the FFR-based approach nonsignificant.

## Linked entities

- **Diseases:** coronary artery disease (MONDO:0005010)

## Full-text entities

- **Diseases:** NTVF (MESH:D051437)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11140391/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11140391/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC11140391/full.md

---
Source: https://tomesphere.com/paper/PMC11140391